Spectrum Pharma (SPPI) Tops Q2 EPS by 21c
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Price: $1.03 --0%
Financial Fact:
Research and development: 13.29M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 13.29M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Spectrum Pharma (NASDAQ: SPPI) reported Q2 EPS of ($0.01), $0.21 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $44.98 million versus the consensus estimate of $34.48 million.
For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
- INVO Fertility (IVF) Tops Q2 EPS by 105c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
